Acquisition cue Boldscience was acquired by Minds + Assembly, signaling consolidation in medical communications and potential client cross-sell opportunities through the combined network and expanded service offerings.

Specialized leadership New SVP Kristin Ludwig appointed to lead patient advocacy and engagement, creating a dedicated vector to pursue pharma programs focused on patient-centric communication and advocacy partnerships.

Strategic positioning Positioned as a scientifically creative global medical communications agency within a broader intelligence-backed group, presenting a compelling story for pharma clients seeking integrated, multidisciplinary storytelling and technical credibility.

Market potential Revenue band indicates mid-market to upper-mid market scale with sizable operations; target opportunities likely in large pharma and mid-sized biotech needing scalable medical education, evidence generation, and patient engagement programs.

Talent and growth Recent hires and expansion plans (SVP appointment) point to investment in specialty divisions and talent acquisition for oncology and patient advocacy, suggesting opportunities to pitch expanded services and custom programs.